HIT Consultant November 5, 2020
Ram Sathia, VP of Intelligent Automation at PK 1

While most of the public’s attention is focused on the horse race for an approved COVID-19 vaccine, another major hurdle lies just around the corner: the distribution of hundreds of millions of vaccine doses. In today’s highly complex and disconnected health data landscape, technologies like AI, Machine Learning, and robotic process automation (RPA) will be essential to making sure that the highest-risk patients receive the vaccine first.

Why identifying at-risk patients is incredibly difficult

Once a vaccine is approved, it will take months or years to produce and distribute enough doses for the U.S.’ 330 million residents. Hospital systems, primary care physicians (PCPs), and provider networks will inevitably need to prioritize administration to at-risk patients, potentially focusing on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Robotics/RPA, Technology
Investing in Humanoid Robots. It’s Not Easy.
Robot-Inspired Therapy Could Help Children with Autism
Generative AI is speeding up human-like robot development. What that means for jobs
Nvidia's DrEureka outperforms humans in training robotics systems
Ready for Robots?

Share This Article